Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 15,936 | 4,245 | 1,381 | 3 |
| Receivables | 299 | 194 | 1 | 2 |
| Inventories | 260 | 139 | N/A | N/A |
| TOTAL | $16,749 | $4,862 | $1,382 | $5 |
| Non-Current Assets | ||||
| PPE Net | 2,222 | 2,160 | 7 | 32 |
| Intangibles | 540 | 0 | 0 | 0 |
| Other Non-Current Assets | 134 | 236 | 175 | 26 |
| TOTAL | $2,896 | $2,396 | $182 | $57 |
| Total Assets | $19,645 | $7,258 | $1,564 | $62 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | N/A | N/A | N/A | 600 |
| Accounts payable and accrued liabilities | 1,461 | 1,881 | 208 | 148 |
| Accrued Expenses | 536 | 112 | 23 | 227 |
| TOTAL | $2,381 | $2,051 | $512 | $1,441 |
| Non-Current Liabilities | ||||
| Deferred Revenues | 384 | 57 | 280 | 360 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 850 |
| TOTAL | $N/A | $N/A | $N/A | $850 |
| Total Liabilities | $2,381 | $2,051 | $512 | $2,291 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 71 | 41 | 41 | N/A |
| Common Shares | 27 | 15 | 15 | 1 |
| Retained earnings | -34,000 | -20,399 | -4,129 | -2,633 |
| Other shareholders' equity | 374 | 14 | 0 | -50 |
| TOTAL | $17,264 | $5,207 | $1,052 | $-2,229 |
| Total Liabilities And Equity | $19,644 | $7,258 | $1,564 | $62 |